The Los Angeles Superior Court is the site of a new product liability suit involving Bayer’s birth control pills marketed under the brand names Yaz and Yasmin. The controversial oral contraceptives, made with a fourth-generation progestin known to increase blood clot formation, have been associated with life-threatening health complications including... Read more »

The judge overseeing coordination of Zoloft birth defects lawsuits in Pennsylvania has excluded the testimony of one of the expert witnesses for the plaintiff. Judge Cynthia Rufe determined that testimony provided by Dr. Anick Berard will not be allowed because the methods by which she drew her conclusions were “scientifically... Read more »

In the wake of an Actos bladder cancer lawsuit verdict in April of this year, Takeda Pharmaceuticals and its U.S. partner Eli Lilly are now seeking a new trial or a reversal of the judgment, which includes both $1.5 million in compensatory damages for the plaintiff and a combined $9... Read more »

Blue Cross/ Blue Shield of Massachusetts has taken legal action against pharmaceutical giant Takeda, claiming the company failed to warn consumers and the medical community about the association between Actos and bladder cancer. The healthcare provider is now seeking compensation for costs of bladder cancer treatment for hundreds of their... Read more »

All testosterone therapy lawsuits filed in U.S. District Courts nationwide, alleging injuries because of Low T treatments, will now go before one judge in the Northern District of Illinois in centralized litigation known as “multidistrict litigation” or MDL. This move comes on the heels of June 6 order by a... Read more »

On May 21, 2014, Fresenius Medical Care announced an expanded Naturalyte recall due to bacterial contamination.  The product recall was first issued in April after Halomonas bacteria was found in several lots of the dialysate additive.  The amended Class I recall now affects 56 lots of Naturalyte. The acid concentrates,... Read more »

In a statement issued on May 28, 2014, the pharmaceutical giant Boehringer Ingelheim announced that they had reached a settlement agreement with plaintiffs who filed lawsuits with regard to side effects from Pradaxa, a medication designed and manufactured by the company. The Pradaxa settlement involves a payout of $650 million,... Read more »

The first federal Zoloft lawsuit trial slated for MDL 2342 has been postponed until January 2015. The In Re: Zoloft (Sertraline Hydrochloride) Products Liability Litigation is being overseen by the Honorable Cynthia M. Rufe, who issued a pretrial order on May 1 which indicated the case would be pushed back... Read more »

As the number of testosterone therapy lawsuits continues to rise nationwide, efforts to coordinate the litigation have met with a minor snag. While most companies listed as defendants on these cases agree coordination of litigation is the best choice, one manufacturer of testosterone treatment, is opposing the move. How this... Read more »

With Pradaxa lawsuits on the rise, drug manufacturer Boehringer Ingelheim just suffered another public relations blow with a new report from the healthcare information company AdverseEvents. The company compared adverse events linked to three new anticoagulant drugs on the market today; finding Pradaxa and Xarelto fell far behind Eliquis in... Read more »